Weesp, Netherlands

Christophorus M Keet

This inventor holds 1 USPTO granted patent. Top assignee: Duphar International Research Bv. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christophorus M Keet. Retrieved from https://idiyas.com/inventor/christophorus-m-keet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christophorus M Keet: Innovator in Cytostatic Compounds

Introduction

Christophorus M Keet is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of chemistry, particularly in the development of new compounds with potential therapeutic applications.

Latest Patents

One of his key patents is focused on di- and tetrahydroisoquinoline derivatives. This invention relates to new di- and tetrahydroisoquinoline derivatives that exhibit interesting cytostatic properties. The patent also covers the preparation of these new compounds and compositions that include such compounds as cytostatically active substances. Christophorus holds 1 patent in this area.

Career Highlights

Christophorus M Keet is associated with Duphar International Research Bv, where he has been involved in innovative research and development. His work has contributed to advancements in the pharmaceutical industry, particularly in the search for effective cytostatic agents.

Collaborations

He has collaborated with notable colleagues such as Maurits E Vandewalle and Johan T Van Der Eycken, enhancing the research output and innovation at Duphar International Research Bv.

Conclusion

Christophorus M Keet's work in developing di- and tetrahydroisoquinoline derivatives showcases his commitment to advancing medical science through innovation. His contributions are valuable in the ongoing quest for effective treatments in the field of cytostatics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…